Literature DB >> 19217046

Cellular mesoblastic nephroma in an infant: report of the cytologic diagnosis of a rare paediatric renal tumor.

Ruchika Gupta1, Sandeep R Mathur, Priti Singh, Sandeep Agarwala, S Datta Gupta.   

Abstract

Congenital mesoblastic nephroma is a rare pediatric tumor with a favorable clinical outcome. Cytological features of this uncommon tumor and diagnostic difficulties with other commoner pediatric renal neoplasms have been inadequately discussed in the available literature. We describe the case of a 1-year-old girl who presented with a right renal mass. Fine-needle aspiration smears consisted of a few cellular clusters of spindle cells with mitotic activity and mild nuclear pleomorphism. No blastema was identified. A cytologic impression of mesoblastic nephroma was rendered, which was confirmed on histopathological examination of the right nephrectomy specimen as a cellular mesoblastic nephroma. Cytologic diagnosis of mesoblastic nephroma has important prognostic and therapeutic implications. The cytopathologist should carefully evaluate smears from such patients and attempt to differentiate mesoblastic nephroma from Wilms' tumor and clear cell sarcoma. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217046     DOI: 10.1002/dc.21028

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  Fine-needle aspiration cytopathology in the diagnosis of Wilms tumor.

Authors:  I Fernández-Pineda; R Cabello; J A García-Cantón; S Pérez-Bertolez; I Tuduri; G Ramírez; C Márquez; J C de Agustín
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

2.  Authors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals - A five year (2007-2011) experience.

Authors:  Nora K Frisch; Romil Nathan; Yasin K Ahmed; Vinod B Shidham
Journal:  Cytojournal       Date:  2014-04-29       Impact factor: 2.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.